Top Markets
#1 Black Phoenix Black Phoenix +355.64%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.18%
#4 Akedo Akedo +52.43%
#5 Acurast Acurast +33.30%
#6 BasedHype BasedHype +25.79%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.22%
#8 Avantis Avantis +22.42%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.64%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Pineapple, Inc. Pineapple, Inc.

Pineapple, Inc.

PNPL
Pozycja w akcjach #41018
Serving the cannabis industry, Pineapple, Inc. functions as a portfolio... Serving the cannabis industry, Pineapple, Inc. functions as a portfolio management firm. Its extensive asset portfolio encompasses a range of offerings, including operational guidance, technological support, intellectual property rights, and real estate rentals tailored for cannabis enterprises. The company also maintains equity investments in both retail and manufacturing segments of the cannabis market. Beyond these, Pineapple extends financing to its cannabis-focused clients, manages property leases for them, and delivers consulting services and technological expertise to facilitate the growth, enhancement, or establishment of new and existing business structures. Established in 1983, the firm's main offices are located in Los Angeles, California.
Cena akcji
$0.0007
Ostatnia synchronizacja: 2026-08-12
Kapitalizacja rynkowa
$51.17K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-99.42%
Kraj
US
Handel Pineapple, Inc. (PNPL)

Kategoria

Healthcare
Zyski dla Pineapple, Inc. (PNPL)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Pineapple, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Pineapple, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US